31 July 2026 Quarterly activities report for the period ended 30 June 2026 Highlights: • Strategic decision to bring development capability onshore to Australia, with key analytic and lab equipment ordered for delivery this quarter • Domestic expansion progressing well with...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Nanollose
- Half Yearly Report and Accounts
- Appendix 4E & Annual Report to Shareholders
- Andrew Moullin Appointed as MD/CEO
- Entitlement Issue Prospectus
- Strategic $2.1M Capital Raising
Later from Nanollose
- Application for quotation of securities - NC6
- Engineering Team Expanded For Pilot Facility Development
- Notification regarding unquoted securities - NC6
- Appendix 4G & Corporate Governance Statement
- Change in substantial holding
